What is neuromodulation and can it help peripheral neuropathy patients manage pain? Dr. Brian Kopell and Dr. Shanna Patterson of Mt. Sinai West help answer questions for the Foundation for Peripheral Neuropathy.
Studies to explore how myrcene, other cannabinoid-based ingredients can treat chronic-neuropathic pain
Amid growing public and government concerns regarding opioid use, GBS Global Biopharma, Inc. will conduct preclinical studies on its proprietary chronic-neuropathic pain formulations in collaboration with National Research Council Canada (NRC).
“Providing sustained relief from chronic-neuropathic pain would bring quality of life to tens of millions of patients throughout the world who suffer from conditions such as … peripheral neuropathy.”
Out-of-pocket costs for neurologic medications rise sharply over 12 years
Did you know that one in six people lives with a neurologic disease or disorder? Did you know that the annual cost of treating neurologic disorders in the United States is more than $500 billion?